| Literature DB >> 25778282 |
L T P Tu1, N V M Hoang1, N V Cuong1, J Campbell1, J E Bryant1, N T Hoa1, B T Kiet2, C Thompson1, D T Duy1, V V Phat1, V B Hien2, G Thwaites1, S Baker1, J J Carrique-Mas1.
Abstract
We investigated the prevalence, diversity, and antimicrobial resistance (AMR) profiles of non-typhoidal Salmonella (NTS) and associated risk factors on 341 pig, chicken, and duck farms in Dong Thap province (Mekong Delta, Vietnam). Sampling was stratified by species, district (four categories), and farm size (three categories). Pooled faeces, collected using boot swabs, were tested using ISO 6575: 2002 (Annex D). Isolates were serogrouped; group B isolates were tested by polymerase chain reaction to detect S. Typhimurium and (monophasic) serovar 4,[5],12:i:- variants. The farm-level adjusted NTS prevalence was 64·7%, 94·3% and 91·3% for chicken, duck and pig farms, respectively. Factors independently associated with NTS were duck farms [odds ratio (OR) 21·2], farm with >50 pigs (OR 11·9), pig farm with 5-50 pigs (OR 4·88) (vs. chickens), and frequent rodent sightings (OR 2·3). Both S. Typhimurium and monophasic S. Typhimurium were more common in duck farms. Isolates had a high prevalence of resistance (77·6%) against tetracycline, moderate resistance (20-30%) against chloramphenicol, sulfamethoxazole-trimethoprim, ampicillin and nalidixic acid, and low resistance (<5%) against ciprofloxacin and third-generation cephalosporins. Multidrug resistance (resistance against ⩾3 classes of antimicrobial) was independently associated with monophasic S. Typhimurium and other group B isolates (excluding S. Typhimurium) and pig farms. The unusually high prevalence of NTS on Mekong Delta farms poses formidable challenges for control.Entities:
Keywords: Epidemiology; Salmonella; zoonoses
Mesh:
Year: 2015 PMID: 25778282 PMCID: PMC4595858 DOI: 10.1017/S0950268815000102
Source DB: PubMed Journal: Epidemiol Infect ISSN: 0950-2688 Impact factor: 4.434
Crude farm-level prevalence by farm category (Dong Thap, Mekong Delta, 2012)
| Target species | No. farms | Small | Medium | Large | |||
|---|---|---|---|---|---|---|---|
| No. positive/ total | Prevalence | No. positive/ total | Prevalence | No. positive/ total | Prevalence | ||
| Chicken | 117 | 22/36 | 61·1% | 24/42 | 57·1% | 28/39 | 71·8% |
| Duck | 118 | 32/35 | 91·4% | 45/50 | 90·0% | 33/35 | 94·3% |
| Pig | 104 | 34/37 | 91·9% | 32/38 | 84·2% | 25/29 | 86·2% |
| 341 | 88/108 | 81·5% | 101/130 | 79/6% | 86/103 | 84·2% | |
Fig. 1.Farm-level prevalence of non-typhoidal Salmonella (NTS) adjusted for the sampling frame, by host species (chickens, ducks, pigs) (lines indicate 95% confidence intervals) (Dong Thap, Mekong Delta, 2012).
Fig. 2.Distribution of farms by number of boot swabs positive for non-typhoidal Salmonella, presented separately by host species and size (Dong Thap, Mekong Delta, 2012).
Significant risk factors for NTS, S. Typhimurium and monophasic S. Typhimurium at sample level (Dong Thap, Mekong Delta, 2012)
| OR | 95% CI | ||
|---|---|---|---|
| Animal species (baseline = chicken farm) | 1·0 | — | — |
| Pig farm 5–50 pigs | 4·88 | 2·83–8·43 | <0·001 |
| Pig farm >50 pigs | 11·87 | 4·20–33·53 | <0·001 |
| Duck farm | 21·17 | 8·39–53·46 | <0·001 |
| Rodents seen at least weekly | 2·29 | 1·06–4·95 | 0·034 |
| Male farmer | 2·47 | 1·05–5·81 | 0·039 |
| Interaction rats seen at least weekly × duck farm | 0·26 | 0·09–0·76 | 0·015 |
| Male farmer (baseline = female) | 3·03 | 1·90–4·86 | <0·001 |
| Target species (baseline = pig farm) | 1·0 | — | |
| Chicken | 2·50 | 0·38–15·9 | |
| Duck | 7·44 | 2·0–27·6 | |
| log(human density | 0·50 | 0·31–0·78 | 0·002 |
| Duck target spp. ( | 6·76 | 1·07–42·5 | 0·042 |
| Municipal water | 0·07 | 0·01–0·38 | 0·002 |
| log(density of pig farms | 1·56 | 1·18–2·06 | 0·002 |
NTS, Non-typhoidal Salmonella; OR, odds ratio; CI, confidence interval.
Intercept model 1 (2·60, s.e. = 1·21); intercept model 2 (−4·87, s.e. = 1·62); intercept model 3 (−6·25, s.e. = 1·25);
No. of humans/km2 in commune.
No. of pig farms/km2 in commune.
Percentage of non-typhoidal Salmonella isolates (n = 727) resistant and multi-drug resistant (MDR) tested against a panel of 10 antimicrobials (Dong Thap, Mekong Delta, 2012)
| All serovars | Monophasic | Other group B | Group C | Group D | Other groups | ||
|---|---|---|---|---|---|---|---|
| AMP | 24·2 (21·1–27·3) | 22·0 (10·5–33·5) | 57·8 (43·3–72·2) | 20·8 (14·7–27·0) | 12·9 (6·3–19·4) | 9·4 (1·6–17·3) | 27·7 (22·8–32·7) |
| AUG | 5·1 (3·5–6·7) | 4·0 (0·0–9·4) | 13·3 (3·4–23·3) | 1·8 (0·0–3·8) | 3·0 (0·0–6·3) | 1·0 (0·0–3·7) | 7·4 (4·5–10·3) |
| CRO | 0·7 (0·0–1·3) | 0·1 (0·0–1·0) | 4·4 (0·0–10·5) | 0·6 (0·0–1·8) | 0·1 (0·0–0·7) | 0·1 (0·0–1·0) | 0·6 (0·0–1·5) |
| CAZ | 0·6 (0·0–1·1) | 0·1 (0·0–1·0) | 4·4 (0·0–10·5) | 0·1 (0·0–0·6) | 0·1 (0·0–0·7) | 0·1 (0·0–1·0) | 0·6 (0·0–1·5) |
| TE | 77·6 (74·5–80·6) | 86·0 (76·4–95·6) | 86·7 (76·7–96·6) | 87·5 (82·5–92·5) | 65·3 (56·1–74·6) | 67·9 (55·4–80·5) | 75·2 (70·4–80·0) |
| C | 27·2 (24·0–30·5) | 18·0 (7·4–28·6) | 35·6 (21·6–49·5) | 39·9 (32·5–47·3) | 5·0 (0·7–9·2) | 0·1 (0·0–1·0) | 32·6 (27·4–37·8) |
| NA | 22·8 (19·8–25·9) | 12·0 (3·0–21·0) | 26·7 (13·7–39·6) | 37·5 (30·2–44·8) | 8·9 (3·4–14·5) | 9·4 (1·6–17·3) | 22·9 (18·2–27·6) |
| CIP | 2·8 (1·6–3·9) | 0·1 (0·0–1·0) | 8·9 (0·6–17·2) | 6·0 (2·4–9·5) | 0·1 (0·0–0·7) | 0·1 (0·0–1·0) | 1·9 (0·4–3·5) |
| CN | 4·5 (3·0–6·1) | 6·0 (0·0–12·6) | 20·0 (8·3–31·7) | 7·1 (3·2–11·0) | 0·1 (0·0–0·7) | 0·1 (0·0–1·0) | 2·9 (1·0–4·8) |
| SXT | 27·0 (23·7–30·2) | 26·0 (13·8–38·2) | 37·8 (23·6–51·9) | 36·9 (29·6–44·2) | 8·9 (3·4–14·5) | 0·1 (0·0–1·0) | 30·6 (25·5–35·8) |
| MDR | 30·1 (28·4–31·8) | 22·0 (10·5–33·5) | 37·8 (23·6–51·9) | 42·9 (35·4–50·3) | 11·9 (5·6–18·2) | 9·4 (1·5–17·3) | 32·9 (27·7–38·1) |
Values given are % (95% confidence interval).
AMP, ampicillin; AUG, amoxicillin/clavulanic acid; CRO, ceftriaxone; CAZ, ceftazidime; TE, tetracycline; C, chloramphenicol; NA, nalidixic acid; CIP, ciprofloxacin; CN, gentamicin, SXT, sulfamethoxazole-trimethoprim.
Results of multivariable-level model investigating risk factors for MDR in 727 NTS isolates (Dong Thap, Mekong Delta, 2012)
| Variable | Level | OR | 95% CI | |
|---|---|---|---|---|
| Animal species | Baseline = chicken and duck farm | 1·0 | — | — |
| Pig farm | 4·53 | 2·17–9·46 | <0·001 | |
| Type of NTS | Baseline = groups C and D | 1·0 | — | — |
| Monophasic | 18·53 | 4·89–70·24 | <0·001 | |
| 6·23 | 1·67–23·26 | 0·003 | ||
| Other group B | 13·56 | 5·12–35·87 | 0·0 001 | |
| Other groups | 6·35 | 2·62–15·37 | 0·001 | |
| log(density of pig farms | 1·45 | 1·10–1·91 | 0·0 023 |
MDR, Multidrug resistance; NTS, non-typhoidal Salmonella; OR, odds ratio; CI, confidence interval.
Model intercept: −5·38 (s.e. = 0·76).
Isolates belonging to groups other than B, C, or D.
No. of pigs/km2 in the commune;
Serovar identity assigned by MLST to individual serogroup resistance patterns (Dong Thap, Mekong Delta, 2012) (N = 56 patterns). Fully susceptible or tetracycline resistant-only patterns were excluded
| MLST-assigned serovar | Pattern | No. of isolates | No. of farms where present | ||
|---|---|---|---|---|---|
| Chicken | Duck | Pig | |||
| Derby | Other group B: AMP-C-NA-SXT | 1 | 1 | ||
| Other group B: AMP-TE-C-NA-CIP-SXT | 1 | 1 | |||
| Other group B: AMP-TE-C-NA-CN-SXT | 3 | 1 | 2 | ||
| Other group B: AMP-TE-C-NA-SXT | 9 | 1 | 3 | ||
| Other group B: AMP-TE-C | 8 | 1 | 4 | ||
| Other group B: TE-C | 3 | 3 | |||
| Other group B: TE-NA | 2 | 1 | 1 | ||
| Other group B: TE-C-NA | 3 | 1 | 2 | ||
| Indiana | Other group B: AMP-AUG-TE-C-NA-CIP-CN-SXT | 2 | 1 | ||
| Other group B: AMP-TE-C-NA-CIP-CN-SXT | 7 | 2 | 4 | ||
| Other group B: AMP-AUG-TE-C-NA-SXT | 1 | 1 | |||
| Other group B: TE-C-NA-SXT | 24 | 10 | |||
| Other group B: TE-NA-SXT | 9 | 1 | 3 | ||
| Other group B: NA-SXT | 1 | 1 | |||
| Paratyphi B var. Java monophasic | Other group B: CRO-C | 1 | 1 | ||
| Bareilly | Group C: AMP-AUG-TE-NA | 1 | 1 | ||
| Group C: TE-SXT | 1 | 1 | |||
| Hadar | Group C: AMP-AUG-TE | 2 | 1 | 1 | |
| Group C: TE-NA | 2 | 1 | 1 | ||
| Group C: NA | 3 | 1 | 1 | 1 | |
| Litchfield | Group C: AMP-TE-NA | 1 | 1 | ||
| Newport | Group C: TE-C-SXT | 2 | 2 | ||
| Group C: AMP-TE-C-SXT | 4 | 3 | |||
| Rissen | Group C: AMP-TE-C-NA-SXT | 2 | 2 | ||
| Group C: AMP-TE-SXT | 4 | 4 | |||
| Group C: AMP-TE | 2 | 2 | |||
| Group C: TE-C | 1 | 1 | |||
| Group C: AMP | 1 | 1 | |||
| Enteritidis | Group D: AMP-TE-NA | 5 | 1 | 2 | |
| Anatum | Other: AMP-TE-NA-SXT | 1 | 1 | ||
| Other: AMP-TE-SXT | 3 | 3 | |||
| Other: TE-C-SXT | 10 | 1 | 2 | 5 | |
| Other: TE-C-NA | 4 | 2 | 1 | 1 | |
| Other: TE-C | 11 | 5 | 4 | ||
| Other: TE-C-NA-SXT | 2 | 1 | |||
| Other: TE-NA-SXT | 2 | 1 | 1 | ||
| Give | Other: AMP-AUG-CRO-CAZ-TE-C-NA-SXT | 1 | 1 | ||
| Other: AMP-TE-C-NA-CIP-CN-SXT | 1 | 1 | |||
| Other: AMP-TE-C-NA-CIP-SXT | 2 | 1 | 1 | ||
| London | Other: AMP-AUG-TE-C-NA-SXT | 15 | 2 | 7 | 2 |
| Other: AMP-AUG-TE-NA | 1 | 1 | 0 | ||
| Other: AMP-TE-C-NA-SXT | 23 | 5 | 3 | 10 | |
| Other: AMP-TE-C-SXT | 21 | 3 | 10 | ||
| Other: -CRO-TE-NA | 1 | 1 | |||
| Other: -TE–NA-CIP–SXT | 1 | 1 | |||
| Other: -TE-NA-SXT | 2 | 1 | |||
| Other: C-SXT | 2 | 1 | 1 | ||
| Other: TE-NA | 7 | 3 | 3 | ||
| Other: NA | 5 | 4 | 1 | ||
| Other: AMP-C | 1 | 1 | |||
| Senftenberg | Other: AMP-TE-C-CN-SXT | 6 | 5 | 1 | |
| Weltvreden | Other: AMP-AUG-TE-C-NA-CIP-CN-SXT | 2 | 1 | ||
| Other: AMP-AUG-TE | 4 | 2 | 1 | 1 | |
| Other: AMP-TE | 5 | 1 | 4 | ||
| Other: CAZ | 1 | 1 | |||
| Other: NA-SXT | 1 | 1 | |||
MLST, Multilocus sequence typing.